NameFUKUDOME Kenji
DepartmentOrganization for General Education
Job TitleProfessor Degree Obtained
E-mail
Homepage

Detailed Information

Research Field/Keywords for Research Field

  • life science

Education

  • 1984/03, Graduated

Employment Experience

  • 1984/04 - 1988/09 Researcher
  • 1986/09 - 1990/03
  • 1988/10 - 1993/03 Researcher
  • 1993/04 - 1995/07 Research Associate
  • 1995/08 - 1996/03
  • 1996/03 - 2001/06 Research Associate
  • 2001/07 - 2003/09 Associate Professor
  • 2003/10 - 2004/08 Associate Professor, Faculty of Medicine, Saga University
  • 2004/09 - 2007/03 Associate Professor, Medicine, Faculty of Medicine, Saga University
  • 2007/04 - 2013/06 Associate Professor, Medicine, Faculty of Medicine, Saga University
  • 2013/07 - 2014/03 Associate Professor, Center for Comprehensive Community Medicine, Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University
  • 2014/04 - 2015/08 Associate Professor, Organization for General Education, Organization for General Education, Saga University
  • 2015/09 -  *  Professor, Organization for General Education, Organization for General Education, Saga University

Field of Specialization

  • Hematology, Structural biochemistry

Research Topics and Results

  • Hemostatic and protein C pathway dysfunction in the pathogenesis of experimental cerebral malaria. 2022/08
  • Hydrothermal processing of ホイ-glucan from Aureobasidium pullulans produces a low molecular weight reagent that regulates inflammatory responses induced by TLR 2019/04
  • Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice. 2016
  • 水熱処理法で精製した黒酵母βグルカンによるマクロファージ活性化の抑制 2016
  • Inhibition of antibody production in vivo by pre-stimulation of Toll-like receptor 4 before antigen priming is caused by defective B-cell priming and not impairment in antigen presentation 2013
  • Reduced surface expression of TLR4 by a V254I point mutation accounts for the low lipopolysaccharide responder phenotype of BALB/c B cells. 2013
  • Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae 2013
  • Inhibition of primary but not secondary humoral immune responses by pre-injection of an agonistic anti-TLR4/MD-2 antibody. 2011/11
  • Agonistic anti-TLR4 monoclonal antibodies function as immunoadjuvants. 2010/08
  • Lipopolysaccharide- bindingprotein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. 2010/08
  • Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. 2010
  • Organotypic culture of human bone marrow adipose tissue. 2010
  • Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo. 2010
  • Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function. 2010
  • Oligomerization-independent TLR4-signaling in CD14-negative cells 2007/11
  • Adjuvant effects of agonistic anti-TLR4 monoclonal antibody in antibody induction 2007/11
  • プロテインC受容体(EPCR) 2007/09
  • Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography. 2007
  • Preparation and Characterization of Agonistic Monoclonal Antibodies Against Toll-Like Receptor 4-MD-2 Complex. 2007
  • The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1 2005
  • Preparation and Characterization of Monoclonal Antibodies to Thrombomodulin 2005
  • Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2 2005

Books

  • プロテインC受容体(EPCR); 2007/09
    ANNOUNCEMENT INFO.; , 14, 3, 303-306
    AUTHOR; 
  • 血管内皮プロテインCレセプター; 2005
    ANNOUNCEMENT INFO.; , 473-478
    AUTHOR; 

Original Articles

  • Hemostatic and protein C pathway dysfunction in the pathogenesis of experimental cerebral malaria.; 2022/08
    ANNOUNCEMENT INFO.; , 107, 8, 1950-1954
    AUTHOR; O'Regan N, Gegenbauer K, Gleeson EM, Fukudome K, O'Sullivan JM, Drakeford C, Dalton N, Chion A, Brophy TM, Smith OP, Preston RJS, O'Donnell JS.
  • Hydrothermal processing of ホイ-glucan from Aureobasidium pullulans produces a low molecular weight reagent that regulates inflammatory responses induced by TLR; 2019/04
    ANNOUNCEMENT INFO.; Biochem Biophys Res Commun., 511, 2, 318-322
    AUTHOR; Hayashi N, Shoubayashi Y, Kondo N, Fukudome K.
  • Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice.; 2016
    ANNOUNCEMENT INFO.; Infection and Immunity, 84, 7, 1986-93
    AUTHOR; Nakamura S, Iwanaga N, Seki M, Fukudome K, Oshima K, Miyazaki T, Izumikawa K, Yanagihara K, Miyazaki Y, Mukae H, Kohno S
  • Inhibition of antibody production in vivo by pre-stimulation of Toll-like receptor 4 before antigen priming is caused by defective B-cell priming and not impairment in antigen presentation; 2013
    ANNOUNCEMENT INFO.; Int Immunol. 2013 Feb;25(2):117-28., 25, 2, 117-128
    AUTHOR; Rachmawati NM, Fukudome K, Tsuneyoshi N, Bahrun U, Tsukamoto H, Yanagibashi T, Nagai Y, Takatsu K, Ohta S, Kimoto M.
  • Reduced surface expression of TLR4 by a V254I point mutation accounts for the low lipopolysaccharide responder phenotype of BALB/c B cells.; 2013
    ANNOUNCEMENT INFO.; J Immunol., 190, 1, 195-204
    AUTHOR; Tsukamoto H, Fukudome K, Takao S, Tsuneyoshi N, Ohta S, Nagai Y, Ihara H, Miyake K, Ikeda Y, Kimoto M.
  • Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae; 2013
    ANNOUNCEMENT INFO.; Clin Vaccine Immunol., 20, 7, 977-985
    AUTHOR; Tanaka A, Nakamura S, Seki M, Fukudome K, Iwanaga N, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Kohno S.
  • Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.; 2010
    ANNOUNCEMENT INFO.; Int Immunol., 22, 4, 271-280
    AUTHOR; Tsukamoto H, Fukudome K, Takao S, Tsuneyoshi N, Kimoto M
  • Organotypic culture of human bone marrow adipose tissue.; 2010
    ANNOUNCEMENT INFO.; Pathol Int., 60, 4, 259-267
    AUTHOR; Uchihashi K, Aoki S, Shigematsu M, Kamochi N, Sonoda E, Soejima H, Fukudome K, Sugihara H, Hotokebuchi T, Toda S.
  • Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo.; 2010
    ANNOUNCEMENT INFO.; Thromb Haemostasis. 103(6):1239-44., 103, 6, 1239-1244
    AUTHOR; Centelles MN, Puy C, L�pez-Sagaseta J, Fukudome K, Montes R, Hermida J.
  • Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function.; 2010
    ANNOUNCEMENT INFO.; FASEB J., 24, 3, 873-881
    AUTHOR; Minhas N, Xue M, Fukudome K, Jackson CJ.
  • Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects.; 2009
    ANNOUNCEMENT INFO.; Haematologica, 94, 3, 387-94, 94, 3, 387-394
    AUTHOR; *P�rez-Casal M, Downey C, Cutillas-Moreno B, Zuzel M, Fukudome K, Toh CH.
  • Effect of disease activity and corticosteroids on serum levels of soluble endothelial cell protein C receptor in patients with systemic lupus erythematosus.; 2009
    ANNOUNCEMENT INFO.; Mod Rteumatol.19.2.173-9, 19, 2, 173-179
    AUTHOR; ○Koarada S, Tsuneyoshi N, Haruta Y, Tada Y, Mitamura M, Inoue H, Ohta A, Fukudome K, Nagasawa K.
  • Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomelization of TLR4 required for signal transduction.; 2007
    ANNOUNCEMENT INFO.; Cellular Immunology , 244, 1, 57-64
    AUTHOR; Tsuneyoshi N, Kohara J, Bahrun U, Saitoh S-I, Akashi S, Gauchat J-F, Kimoto M, Fukudome K
  • Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography.; 2007
    ANNOUNCEMENT INFO.; Protein Expr Purif.(Academic Press), 56, 1, 138-144
    AUTHOR; Tsukamoto H, Fukudome K, Kohara J, Nakatake H, Kimoto M
  • Preparation and Characterization of Agonistic Monoclonal Antibodies Against Toll-Like Receptor 4-MD-2 Complex.; 2007
    ANNOUNCEMENT INFO.; Hybridoma(Mary Ann Liebert, Inc.), 26, 6, 393-399
    AUTHOR; Bahrun U, Kimoto M, Tsukamoto H, Tsuneyoshi N, Kohara J, Fukudome K
  • Expression of CD180, a Toll-like receptor homologue, is up-regulated in children with Kawasaki disease.; 2006
    ANNOUNCEMENT INFO.; J. Mol. Med., 84, 2, 168-174
    AUTHOR; Imayoshi M, Yamamoto S, Watanabe M, Nishimura S, Tashiro K, Zaitsu M, Takaski H, Kimoto M, Hamasaki Y, Ishii E
  • Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli.; 2006
    ANNOUNCEMENT INFO.; Protein Expr Purif. , 49, 2, 276-283
    AUTHOR; Kohara J, Tsuneyoshi N, Gauchat JF, Kimoto M, Fukudome K
  • Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells.; 2006
    ANNOUNCEMENT INFO.; Br J Haematol. , 133, 5, 550-557
    AUTHOR; Brueckmann M, Nahrup AS, Lang S, Bertsch T, Fukudome K, Liebe V, Kaden JJ, Hoffmann U, Borggrefe M, Huhle G
  • Induction of long-term lipopolysacchride tolerance by an agonistic monoclonal antibody to the Toll-like receptor 4/MD-2 complex.; 2006
    ANNOUNCEMENT INFO.; Clin Vaccine Immunol., 13, 10, 1131-1136
    AUTHOR; Ohta S, Bahrun U, Shimazu R, Matsushita H, Fukudome K, Kimoto M
  • Thrombus and encapsulated hematoma in cerebral cavernous malformations; 2005
    ANNOUNCEMENT INFO.; ACTA NEUROPATHOLOGICA, 109, 5, 503-509
    AUTHOR; Abe, M / Fukudome, K / Sugita, Y / Oishi, T / Tabuchi, K / Kawano, T
  • Activated protein C induces the release of microparticle-associated endothelial protein C receptor; 2005
    ANNOUNCEMENT INFO.; BLOOD, 105, 4, 1515-1522
    AUTHOR; Perez-Casal, M / Downey, C / Fukudome, K / Marx, G / Toh, C. HToh
  • The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1; 2005
    ANNOUNCEMENT INFO.; JOURNAL OF IMMUNOLOGY, 174, 1, 340-344
    AUTHOR; Tsuneyoshi, N / Fukudome, K / Kohara, J / Tomimasu, R / Gauchat, J.-F / Nakatake, H / Kimoto, M
  • Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1; 2005
    ANNOUNCEMENT INFO.; Thromb Haemost, 93, 743-750
    AUTHOR; Brueckmann, M., S. Horn, S. Lang, K. Fukudome, A. Schulze Nahrup, U. Hoffmann, J.J. Kaden, M. Borggrefe, K.K. Haase, and G. Huhle
  • Preparation and Characterization of Monoclonal Antibodies to Thrombomodulin; 2005
    ANNOUNCEMENT INFO.; HYBRIDOMA AND HYBRIDOMICS, 24, 4, 189-196
    AUTHOR; Tsuneyoshi, N / Fukudome, K / Higuchi, K / Kimoto, M
  • Anti-inflammatory effect of activated protein C in gastric epithelial cells; 2005
    ANNOUNCEMENT INFO.; JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 3, 12, 2721-2729
    AUTHOR; NAKAMURA, M / GABAZZA, E. C / IMOTO, I / YANO, Y / TAGUCHI, O / HORIKI, N / Fukudome, K / SUZUKI, K / ADACHI, Y.
  • Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2; 2005
    ANNOUNCEMENT INFO.; CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 12, 11, 1292-1297
    AUTHOR; Koraha, J / Tsuneyoshi, N / Kimoto, M / Gauchat, J.-F / Nakatake, H / Fukudome, K
  • Endothelial Protein C Receptor and Protease-Activated Receptor-1 Mediate Induction of a Wound-Healing Phenotype in Human Keratinocytes by Activated Protein C; 2005
    ANNOUNCEMENT INFO.; JOURNAL OF INVESTIGATIVE DERMATOLOGY, 125, 6, 1279-1285
    AUTHOR; Xue, M / Campbell, D / Sambrook, P. N / Fukudome, K / Jackson, C. J
  • プロテインCとその受容体; 2005
    ANNOUNCEMENT INFO.; , 6, 245-252
    AUTHOR; 
  • Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death; 2004
    ANNOUNCEMENT INFO.; BLOOD, 104, 5, 1369-1374
    AUTHOR; Hurtado, V / Montes, R / Gris, J.-C / Bertolaccini, M. L / Alonso, A / Martinez-Gonzalez, M. A / Khamashta, M. A / Fukudome, K / Lane, D. A. / Hermida, J.
  • Activated Protein C Induces Endothelial Cell Proliferation by Mitogen-Activated Protein Kinase Activation In Vitro and Angiogenesis In Vivo; 2004
    ANNOUNCEMENT INFO.; CIRCULATION RESEARCH, 95, 1, 34-41
    AUTHOR; Uchiba, M / Okajima, K / Oike, Y / Ito, Y / Fukudome, K / Isobe, H / Suda, T
  • Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice.; 2004
    ANNOUNCEMENT INFO.; Blood, 103, 2196-2204
    AUTHOR; Yuda H,Adachi Y,Taguchi O,Gabazza EC,Hataji O,Fujimoto H,Tamaki S,Nishikubo K,Fukudome K,D'Alessandro-Gabazza CN,Maruyama J,Izumizaki M,Iwase M,Homma I,Inoue R,Kamada H,Hayashi T,Kasper M,Lambrecht BN,Bames PJ,SuzukiK.
  • MAb PS7 against human protein S; 2004
    ANNOUNCEMENT INFO.; Hybridoma and Hybridomics 23:389, 2004
    AUTHOR; Tsuneyoshi N,Fukudome K,Kimoto M
  • Current Topics of EPCR; 2003/12
    ANNOUNCEMENT INFO.; , 14, 6, 511-513
    AUTHOR; 
  • Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective; 2003
    ANNOUNCEMENT INFO.; NATURE MEDICINE, 9, 3, 338-342
    AUTHOR; Cheng, T / Liu, D / Griffin, J. H / Fernandez, J. A / Castellino, F / Rosen, E. D / Fukudome, K / Zlokovic, B. V
  • Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1; 2003
    ANNOUNCEMENT INFO.; BLOOD, 101, 12, 4797-4801
    AUTHOR; Domotor, E / Benzakour, O / Griffin, J. H / Yule, D / Fukudome, K / Zlokovic, B. V
  • Activated protein C inhibits the expression of platelet-derived growth fador in the lung.; 2003
    ANNOUNCEMENT INFO.; Am. J. Respir. Crit. Care Med., 167, 10, 1416-1426
    AUTHOR; Shimizu S,Gabazza EC,Taguchi O,Yasui H,Taguchi Y,Hayashi T,Ido M,Shimizu T,Nakagaki T,Kobayashi H,Fukudome K,Tsuneyoshi N,D'Alessandro-Gabazza CN,Izumizaki, Iwase M,Homma I,Adachi Y,Suzuki K.
  • Expression and function of the endothelial protein C receptor in human neutrophils; 2003
    ANNOUNCEMENT INFO.; BLOOD, 102, 4, 1499-1505
    AUTHOR; Sturn, D / H. Kaneider, N. C / Feistritzer, C / Djanani, A / Fukudome, K / Wiedermann, C. J.
  • Characterization of protein C receptor expression in monocytes.; 2001
    ANNOUNCEMENT INFO.; Br. J. Haematol. , 115, 408-414
    AUTHOR; Galligan L, Livingstone W, Volkov Y, Hokamp K, Murphy C, Lawler M, Fukudome K and Smith O
  • Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines.; 2001
    ANNOUNCEMENT INFO.; Thromb. Haemost. , 895, 356-361
    AUTHOR; Tsuneyoshi N, Fukudome K, Horiguchi S, Ye X, Matsuzaki M, Toi M, Suzuki K and Kimoto M
  • Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2.; 2000
    ANNOUNCEMENT INFO.; Biochem. Biophys. Res. Commu., 268, 172-177
    AUTHOR; Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M, Shimazu R, Nagai Y, Fukudome K, Kimoto M and Miyake K
  • 血管内皮細胞における抗血栓性―プロテインC受容体-トロンボモジュリン―; 2000
    ANNOUNCEMENT INFO.; , 55, 2, 168-176
    AUTHOR; 
  • Anti-adhesive function of CD43 130 kDa glycoform expressed in CD4 T lymphocyte clones and in transfectant cell lines.; 2000
    ANNOUNCEMENT INFO.; Blood , 96, 4267-4275
    AUTHOR; Fukuoka M, Fukudome K, Yamashita Y, Tokushima M, Miyake K and Kimoto M
  • Characterization and regulation of the 5'-flanking region of the murine endothelial protein C receptor gene.; 2000
    ANNOUNCEMENT INFO.; J. Biol. Chem. , 275, 12481-12488
    AUTHOR; Gu JM, Fukudome K and Esmon CT
  • Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner.; 2000
    ANNOUNCEMENT INFO.; FEBS Lett. , 477, 3, 208-212
    AUTHOR; Shua F, Kobayashia H, Fukudome K, Tsuneyoshi N, Kimoto M and Terao T
  • Inflammation, sepsis and coagulation.; 1999
    ANNOUNCEMENT INFO.; Haematologica , 84, 3, 254-259
    AUTHOR; Esmon CT, Fukudome K, Mather T, Bode W, Rega LM, Stearns-Kurosawa DJ and Kurosawa S
  • プロテインC活性化機構におけるプロテインCレセプターの役割; 1999
    ANNOUNCEMENT INFO.; , 10, 6, 469-473
    AUTHOR; 
  • MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4.; 1999
    ANNOUNCEMENT INFO.; J. Exp. Med. , 189, 1777-1782
    AUTHOR; Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K and Kimoto M
  • Fibroblasts, glial, and neuronal cells are involved in extravascular prothrombin activation.; 1999
    ANNOUNCEMENT INFO.; J Biochem , 126, 4, 655-661
    AUTHOR; Yamazaki Y, Shikamoto Y, Fukudome K, Kimoto M, Morita T
  • The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries.; 1999
    ANNOUNCEMENT INFO.; Biochem Biophys Res Commun. , 259, 3, 671-677
    AUTHOR; Ye X, Fukudome K, Tsuneyoshi N, Satoh T, Tokunaga O, Sugawara K, Mizokami H, Kimoto M
  • Activation mechanism of anticoagulant protein C in large blodd vessels involving the endothelial cell protein C receptor.; 1998
    ANNOUNCEMENT INFO.; J. Exp. Med. , 187, 1029-1035
    AUTHOR; 2. Fukudome K, Ye X, Tsuneyoshi N, Tokunaga O, Sugawara K, Mizokami H and Kimoto M
  • プロテインC受容体; 1997
    ANNOUNCEMENT INFO.; , 6, 4, 399-406
    AUTHOR; 
  • プロテインCレセプター; 1996
    ANNOUNCEMENT INFO.; , 33, 2, 146-155
    AUTHOR; 
  • The endothelial cell protein C receptor: Cell Surface expression and direct ligand binding by the solubule receptor; 1996
    ANNOUNCEMENT INFO.; J. Biol. Chem., 271, 17491-17498
    AUTHOR; Fukudome K, Kurosawa S, Stearns-Kurosawa DJ, He X, Rezaie AR, Esmon CT
  • The endothelial cell protein C receptor: Inhibition of activated protein C antiacoagulant functiiion without modulation of reaction with protease inhibitors.; 1996
    ANNOUNCEMENT INFO.; J. BIol. Chem, 271, 17499-17503
    AUTHOR; Regan LM, Sterns-Kurosawa DJ, Kurosawa S, Molica J, Fukudome K Esmon CT

General Lectures

  • 水熱処理法で精製した黒酵母βグルカンによるマクロファージ活性化の抑制; 2016
    ANNOUNCEMENT INFO.; 
    AUTHOR; 
  • Inhibition of primary but not secondary humoral immune responses by pre-injection of an agonistic anti-TLR4/MD-2 antibody.; 2011/11
    ANNOUNCEMENT INFO.; 
    AUTHOR; Rachmawati NM, Fukudome K, Tsuneyoshi N, Uleng B, Ohta S, Kimoto M
  • Agonistic anti-TLR4 monoclonal antibodies function as immunoadjuvants.; 2010/08
    ANNOUNCEMENT INFO.; 14th International Congress of Immunology 2010, 8, 22-27
    AUTHOR; Rachmawati NM, Uleng B, Fukudome K, Kimoto M
  • Lipopolysaccharide- bindingprotein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.; 2010/08
    ANNOUNCEMENT INFO.; 14th International Congress of Immunology 2010, 8, 22-27
    AUTHOR; Tsukamoto H, Fukudome K, Takao S, Tsuneyoshi N, Kimoto M.
  • 機能抑制型ヒトTLR4抗体; 2008
    ANNOUNCEMENT INFO.; , 38, 169
    AUTHOR; 
  • Oligomerization-independent TLR4-signaling in CD14-negative cells; 2007/11
    ANNOUNCEMENT INFO.; 
    AUTHOR; 
  • Adjuvant effects of agonistic anti-TLR4 monoclonal antibody in antibody induction; 2007/11
    ANNOUNCEMENT INFO.; 
    AUTHOR; Fukudome K, Kohara J, Tsukamoto H,Tsuneyoshi N, Kimoto M
  • Charaterization of agonistic monoclonal antibodies against murine TLR4/MD-2.; 2006/12
    ANNOUNCEMENT INFO.; 第36回日本免疫学会総会 大阪市, 36, 43
    AUTHOR; Bahrun U, Fukudome, K, Tsuneyoshi N, Tsukamoto H, Kimoto M
  • Oligomelization- independent signal transduction in innate immunity by agonistic anti-TLR4/MD-2 monoclonal antibodies.; 2006/12
    ANNOUNCEMENT INFO.; 第36回日本免疫学会総会 大阪市, 36, 43
    AUTHOR; Kohara J, Tsukamoto H, Bahrun U, Tsuneyoshi N, Fukudome, K, Kimoto M
  • Murine B cell proliferation induced by agonistic anti-TLR4/MD-2 monoclonal antibodies.; 2006/12
    ANNOUNCEMENT INFO.; 第36回日本免疫学会総会 大阪市, 36, 223
    AUTHOR; Tsukamoto H, Fukudome K, Bahrun U, Kohara J , Kimoto M
  • CD14ロイシンリッチリピート1-3の機能解析; 2005/12
    ANNOUNCEMENT INFO.; , 35, 44
    AUTHOR; 
  • LPS結合蛋白(LBP)の大腸菌での発現と機能解析; 2005/12
    ANNOUNCEMENT INFO.; , 35, 44
    AUTHOR; 
  • 大腸菌によるCD14の発現と機能解析; 2004/12
    ANNOUNCEMENT INFO.; , 34, 53
    AUTHOR; 
  • MD-2のLPS結合におけるヒトとマウスの違い; 2004/12
    ANNOUNCEMENT INFO.; , 34, 48
    AUTHOR; 
  • Binding characteristics of MD proteins to lpopolysaccharide.; 2004/07
    ANNOUNCEMENT INFO.; 12th International Congress of Immunology 2004,7,21. Online Abstracts (http://www.immuno2004.org/onlineabstracts/allposters/1684.html)
    AUTHOR; Fukudome K, Tsuneyoshi N, Tomimasu R, Kohara J, Gauchat F, Kimoto M
  • 脳星細胞系腫瘍の血管内皮細胞におけるEPCR およびTM 発現の免疫組織化学的検討; 2004/06
    ANNOUNCEMENT INFO.; 
    AUTHOR; 
  • A novel isoform of MD-2 that regulates LPS signaling.; 2004/02
    ANNOUNCEMENT INFO.; 10th International Conference on Lymphocyte Activation and Immune Regulation 2004,2,6. Abstracts, 3
    AUTHOR; Ohta S, Bahrun U, Fukudome K, Kimoto M
  • MD-2蛋白の大腸菌での発現; 2003/12
    ANNOUNCEMENT INFO.; , 33, 126
    AUTHOR; 
  • MD-2アイソフォームによるLPSシグナル制御; 2003/12
    ANNOUNCEMENT INFO.; , 33, 121
    AUTHOR; 
  • CHO細胞でのMD-1の発現とその構造解析; 2003/12
    ANNOUNCEMENT INFO.; , 33, 124
    AUTHOR; 
  • Expression of MD-1 protein in CHO cells.; 2003
    ANNOUNCEMENT INFO.; 第76回生化学会大会 2003,10,16. 生化学, 75, 873
    AUTHOR; Tsuneyoshi N, Tomimasu R, Fukudome K, Kimoto M
  • 血管内皮プロテインCレセプター(EPCR)とトロンボモジュリン(TM)の会合; 2002/10
    ANNOUNCEMENT INFO.; , 74, 215
    AUTHOR; 
  • 血管内皮細胞上でのプロテインC活性化機構; 2001/11
    ANNOUNCEMENT INFO.; , 67
    AUTHOR; 
  • 血管内皮プロテインCレセプター(EPCR)とトロンボモジュリン(TM)の会合; 2001/10
    ANNOUNCEMENT INFO.; , 73, 787
    AUTHOR; 
  • Anti-adhesive function of CD43 130-kDa glycoform.; 2001
    ANNOUNCEMENT INFO.; 11th International Congress of Immunology 2001,7,27. Program , 28
    AUTHOR; Kimoto M, Fukudome K, Yamashita Y, Tokushima M, Miyake K, Fukuoka M
  • プロテインCのGlaドメインを介した結合様式の解析; 2000/10
    ANNOUNCEMENT INFO.; , 72, 8, 780
    AUTHOR; 
  • 血管内皮細胞上におけるプロテインC活性化機構; 2000/07
    ANNOUNCEMENT INFO.; , 35
    AUTHOR; 
  • Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor.; 2000/06
    ANNOUNCEMENT INFO.; 15th International Congress of Fibrinolysis and Proteolysis 2000,6,29. Program , 51
    AUTHOR; Fukudome K
  • プロテインCの軽鎖を認識するモノクローナル抗体はEPCRへの結合を阻害する; 1999/10
    ANNOUNCEMENT INFO.; , 71, 8, 92
    AUTHOR; 
  • マウス EPCRに対するモノクローナル抗体の作製と解析; 1999/10
    ANNOUNCEMENT INFO.; , 71, 8, 91
    AUTHOR; 
  • Molecular mechanism for protein C activation.; 1999
    ANNOUNCEMENT INFO.; The first Aso International Meeting 1999,11.19. Abstract, 8-9
    AUTHOR; Fukudome K
  • 白血病及び神経膠芽腫由来細胞株におけるプロテインCレセプター(EPCR)の発現; 1998/10
    ANNOUNCEMENT INFO.; , 70, 8, 748
    AUTHOR; 
  • プロテインCレセプター(EPCR)に対するモノクローナル抗体の作製と機能解析; 1998/10
    ANNOUNCEMENT INFO.; , 70, 8, 1013
    AUTHOR; 
  • プロテインCレセプター; 1997/03
    ANNOUNCEMENT INFO.; , 65, 34
    AUTHOR; 
  • プロテインC受容体; 1996/12
    ANNOUNCEMENT INFO.; , 68, 1679
    AUTHOR; 
  • B/WF1マウス非病原性T細胞クローンに発現する新しいCD43分子アイソフォーム.; 1996/11
    ANNOUNCEMENT INFO.; , 26, 341
    AUTHOR; 
  • プロテインCレセプター; 1996/07
    ANNOUNCEMENT INFO.; , 83
    AUTHOR; 
  • プロテインCレセプター(PCR)の構造と機能; 1996
    ANNOUNCEMENT INFO.; , 68, 589
    AUTHOR; 


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.